本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

碧迪医疗

192.39
+1.130.59%
盘后192.390.00000.00%19:41 EDT
成交量:124.42万
成交额:2.39亿
市值:551.44亿
市盈率:35.17
高:192.98
开:191.00
低:190.83
收:191.26
52周最高:251.99
52周最低:163.33
股本:2.87亿
流通股本:2.86亿
量比:0.64
换手率:0.44%
股息:4.07
股息率:2.12%
每股收益(TTM):5.47
每股收益(LYR):5.88
净资产收益率:6.17%
总资产收益率:3.96%
市净率:2.16
市盈率(LYR):32.70

数据加载中...

2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/02

重要事件披露

Form 8-K - Current report
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/12

重要事件披露

Form 8-K - Current report
2024/06/27

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/27

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/06/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]